Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.
<h4>Background</h4>Though the possibility of using malignant pleural effusions (MPEs) as alternatives for metastatic pleural tumor tissues (MPTTs) in epidermal growth factor receptor (EGFR) mutation test has been examined, due to the lack of studies comparing the results in matching MPEs...
Main Authors: | Dan Liu, Yachao Lu, Zhenli Hu, Ning Wu, Xiaomeng Nie, Yang Xia, Yiping Han, Qiang Li, Guanshan Zhu, Chong Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089946&type=printable |
Similar Items
-
Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
by: Zhihua Guo, et al.
Published: (2019-04-01) -
Malignant pleural mesothelioma with resolution of pleural effusion
by: Sayaka Nishida, et al.
Published: (2023-11-01) -
Derrame pleural neoplásico Malignant pleural effusion
by: Lisete Ribeiro Teixeira, et al.
Published: (2006-08-01) -
Management of malignant pleural effusion with different pleural catheters
by: Sami Karapolat, et al.
Published: (2018-01-01) -
Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma
by: DanHui Huang, et al.
Published: (2023-07-01)